19 Jan – 25 Jan 2026

Australia’s healthtech week signals a shift to a data‑first, AI‑enabled care stack where scalable platforms, funding that avoids equity dilutions, and stronger governance collide to reshape strategy for health systems and providers.

Non‑dilutive funding appetite is rising, with ANDHealth+ reporting a record intake of 90 applications. A 10‑strong shortlist will be announced in February, with up to five winners named in March. The prize package offers milestone funding totaling up to A$5 million over two years, designed to de‑risk early commercialisation while preserving ownership. This devours a key pain point for growth‑stage healthtech: capital that accelerates deployment without the drag of stakeholder equity.

AI and data platforms are moving beyond pilots toward scale in clinical workflows. Heidi, the AI scribe, now features in millions of interactions worldwide, supported by a flexible data model and vector search to accelerate development. On the data side, My Health Record is shifting toward default sharing, with pathology and imaging results uploading automatically and imaging reports moving to immediate release for certain studies from March 2026, enhancing continuity of care and clinician access. Interoperability remains a priority, with GP referrals and care pathways increasingly looped through digital tools that connect primary care with hospital and community services.

The week also spotlights workforce and governance dynamics that shape execution. Regional policy signals in South Australia target GP supply and after‑hours access, while oversubscription in rural training programs underscores the ongoing need for workforce planning that aligns with funding and supervision. Telehealth governance moves to the foreground, with calls for formal standards and vendor accountability to ensure safety and reliability as digital care expands.

Beyond policy, the market sees concrete product and device developments that could alter care delivery. The da Vinci 5 robotic system has gained ARTG listing in Australia, bringing markedly higher processing power and imaging clarity to operating theatres. A new needle‑free adrenaline nasal spray, neffy, marks Australia’s first non‑injectable option for anaphylaxis. And in regional care delivery, the Charm Oncology Information Management System goes live in Victoria, replacing paper workflows with an auditable, integrated platform for prescribing and scheduling. These moves illustrate a trend toward safer, faster, data‑driven care across settings.

Across primary care and preventive health, interoperable data flows and consumer AI tools are set to redefine engagement. Juniper’s GP‑referral loop via Consultmed and Eucalyptus reinforces the potential for closed‑loop care in weight management, while CP Thrive, a consortium project for cerebral palsy care, aims to translate research into practical guidance for families and clinicians. A small but notable genetic signal emerged from Monash, with about 2% of participants carrying high‑risk variants, renewing momentum for broader DNA screening programs integrated with GP stewardship. Finally, attention to device validation and equitable remote monitoring—particularly around pulse oximeters—remains essential as digital health goes mainstream.

• ANDHealth+ intake hits 90 apps; shortlist of 10, up to five winners; up to A$5m total funding over two years signals stronger non‑dilutive support.
• Heidi AI scribe scales to tens of millions of consultations worldwide, powered by a flexible data stack and vector search.
• My Health Record moves to default sharing; pathology/imaging auto‑uploads; March 2026 adds immediate release for X‑ray limb reports.
• South Australia considers GP payroll tax relief and after‑hours care to stabilise rural access; observation on rural training demand.
• Telehealth governance gains urgency with a push for formal standards and vendor accountability.
• da Vinci 5 gains ARTG listing, delivering a substantial upgrade in compute and imaging for robotic surgery.
• Juniper/Consultmed and Eucalyptus enable March 2026 GP referrals, strengthening primary‑to‑specialist care loops.
• Cp Thrive project aims to translate CP research into practical care guidance for families and clinicians.
• Pulse oximeter readings show skin tone bias; calls for validation and equitable remote monitoring are rising.
• Monash pilot identifies 2% carrying high‑risk cancer variants, reinforcing the case for nationwide DNA screening with GP governance.

Overall, the week reinforces a trajectory where AI‑enabled data platforms, improved interoperability, and targeted funding align to lift care delivery, efficiency and prevention in Australia.